Economics of cancer biomarkers

JOURNAL ARTICLE published November 2012 in Personalized Medicine

Authors: John E Schneider | Manpreet K Sidhu | Cynthia Doucet | Noemi Kiss | Robert L Ohsfeldt | Donald Chalfin

New indication for Herceptin in early stage breast cancer

JOURNAL ARTICLE published May 2005 in Personalized Medicine

Pharmacogenetics and individualized medicine – bridging the gap between pharmacogenetic research and the patient

JOURNAL ARTICLE published March 2005 in Personalized Medicine

Authors: Julia Kirchheiner

Pharmacogenetics of oral anticoagulants

JOURNAL ARTICLE published March 2005 in Personalized Medicine

Authors: Ann K Daly

Pharmacogenomics of MDR and MRP subfamilies

JOURNAL ARTICLE published 1 December 2004 in Personalized Medicine

Authors: Noboru Okamura | Toshiyuki Sakaeda | Katsuhiko Okumura

Workshop Introduction: Personalized medicine: desirable, affordable, attainable?

JOURNAL ARTICLE published May 2005 in Personalized Medicine

Authors: David Gurwitz | Gregory Livshits

Genomas, Inc.

JOURNAL ARTICLE published 1 December 2004 in Personalized Medicine

Authors: Gualberto Ruano | Robert Scherrer

Innogenetics NV

JOURNAL ARTICLE published May 2005 in Personalized Medicine

Authors: Fred Shapiro | Viviane Smeets | Jean-Christophe Donck | Wim Ottevaere

The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations

JOURNAL ARTICLE published 1 December 2004 in Personalized Medicine

Authors: Julia Kirchheiner | Martina Tsahuridu | Wafaa Jabrane | Ivar Roots | Jürgen Brockmöller

Personalized medicine conference

JOURNAL ARTICLE published November 2005 in Personalized Medicine

Authors: KK Jain

Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk

JOURNAL ARTICLE published August 2007 in Personalized Medicine

Authors: Stephanie L Van Bebber | Su-Ying Liang | Kathryn A Phillips | Deborah Marshall | Judith Walsh | Nathalie Kulin

Pharmacogenomics and drug development: the impact of US FDA postapproval tracking on clinical pharmacology

JOURNAL ARTICLE published March 2008 in Personalized Medicine

Authors: Erin Farrell | Jonathan Usuka

Role of proteomics in personalized medicine

JOURNAL ARTICLE published August 2006 in Personalized Medicine

Authors: David H Geho | James N Cooper | Virginia Espina | Enrico Garaci | Emanuel F Petricoin 3rd | Lance Liotta

Genetic structure in human populations: implications for the personalized medicine value chain

JOURNAL ARTICLE published February 2006 in Personalized Medicine

Authors: John A Fossella

Systems biology and personalized prevention

JOURNAL ARTICLE published May 2009 in Personalized Medicine

Authors: Gérard Siest

What are the limits of the duty of care? The case of clinical genetics

JOURNAL ARTICLE published March 2008 in Personalized Medicine

Authors: Pascal Borry | Kris Dierickx

The biomarker revolution: a step toward personalized medicine

JOURNAL ARTICLE published November 2008 in Personalized Medicine

Authors: Jean-Yves Bonnefoy

Personalized medicine: using effective partnering for managing the risk of legal liability

JOURNAL ARTICLE published August 2007 in Personalized Medicine

Authors: Mollie Roth

Monogram Biosciences, Inc.

JOURNAL ARTICLE published November 2005 in Personalized Medicine

Authors: Alf Merriweather

Personalizing medicine through targeted agents, capitalizing on pathway dysregulation and biomarker use

JOURNAL ARTICLE published November 2008 in Personalized Medicine

Authors: Kim Marie Hirshfield